Recent studies reported that ATG9B is highly expressed in some cancer, including cervical cancer [19] and renal clear cell carcinoma [20], while it is lower expressed in hepatocellular carcinoma [21] and breast cancer [22]. Here, ATG9B is linked to hepatocellular carcinoma.